Repositori URV

Author, as appears in the article.: Berenguer, J; Diez, C; Martin-Vicente, M; Mican, R; Perez-Elias, MJ; Garcia-Fraile, LJ; Vidal, F; Suarez-Garcia, I; Podzamczer, D; Del Romero, J; Pulido, F; Iribarren, JA; Gutierrez, F; Poveda, E; Galera, C; Izquierdo, R; Asensi, V; Portilla, J; Lopez, JC; Arribas, JR; Moreno, S; Gonzalez-Garcia, J; Resino, S; Jarrin, I

Department: Medicina i Cirurgia

URV's Author/s: Vidal Marsal, Francisco

Keywords: Seroprevalence Serology Sars-cov-2 Risk-factors Infection Hiv Covid-19 Coronavirus disease 2019 Clinical characteristics Antibodies

Abstract: Objectives: We aimed to assess the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and factors associated with seropositivity and asymptomatic coronavirus disease 2019 (COVID-19) among people with HIV (PWH).Methods: This was a cross-sectional study carried out within the cohort of the Spanish HIV Research Network. Participants were consecutive PWH with plasma collected from 1st April to 30th September 2020. We determined SARS-CoV-2 antibodies (Abs) in plasma. Illness severity (NIH criteria) was assessed by a review of medical records and, if needed, participant interviews. Multivariable logistic regression analysis was used to identify predictors of seropositivity among the following variables: sex, age, country of birth, education level, comorbidities (hypertension, chronic heart disease, diabetes mellitus, non-AIDS-related cancer, chronic kidney disease, cirrhosis), route of HIV acquisition, prior AIDS, CD4+ cell count, HIV viral load, nucleoside/nucleotide reverse transcriptase inhibitor (N [t]RTI) backbone, type of third antiretroviral drug, and month of sample collection.Results: Of 1076 PWH (88.0% males, median age 43 years, 97.7% on antiretroviral therapy, median CD4+ 688 cells/mm(3), 91.4% undetectable HIV viral load), SARS-CoV-2 Abs were detected in 91 PWH, a seroprevalence of 8.5% (95%CI 6.9-10.3%). Forty-five infections (45.0%) were asymptomatic. Variables independently associated with SARS-CoV-2 seropositivity were birth in Latin American countries versus Spain (adjusted odds ratio (aOR) 2.30, 95%CI 1.41-3.76, p 0.001), and therapy with tenofovir disoproxil fumarate plus emtricitabine (TDF/FTC) versus tenofovir alafenamide (TAF)/FTC as the N(t)RTI backbone (aOR 0.49, 95%CI 0.26-0.94, p 0.031).Conclusions: Many SARS-CoV-2 infections among PWH were asymptomatic, and birth in Latin American countries increased the risk of SARS-CoV-2 seropositivity. Our analysis, adjusted by comorbidities and other variables, suggests that TDF/FTC may prevent SARS-CoV-2 infection among PWH. (C) 2021 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.

Thematic Areas: Saúde coletiva Química Odontología Microbiology (medical) Microbiology Medicine (miscellaneous) Medicina veterinaria Medicina iii Medicina ii Medicina i Interdisciplinar Infectious diseases Farmacia Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Ciências ambientais Ciências agrárias i Biotecnología Astronomia / física

licence for use: https://creativecommons.org/licenses/by/3.0/es/

Author's mail: francesc.vidal@urv.cat

Author identifier: 0000-0002-6692-6186

Record's date: 2024-07-27

Papper version: info:eu-repo/semantics/publishedVersion

Link to the original source: https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(21)00343-8/fulltext#%20

Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/

Papper original source: Clinical Microbiology And Infection. 27 (11): 1678-1684

APA: Berenguer, J; Diez, C; Martin-Vicente, M; Mican, R; Perez-Elias, MJ; Garcia-Fraile, LJ; Vidal, F; Suarez-Garcia, I; Podzamczer, D; Del Romero, J; Puli (2021). Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort. Clinical Microbiology And Infection, 27(11), 1678-1684. DOI: 10.1016/j.cmi.2021.06.023

Article's DOI: 10.1016/j.cmi.2021.06.023

Entity: Universitat Rovira i Virgili

Journal publication year: 2021

Publication Type: Journal Publications